Updated Date:
29 May 2026
Product Detail:
ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule
Shortage Status:
Current
AUST R:
195804
Availability:
Limited Availability
Active Ingredient:
ropivacaine hydrochloride
Reason:
Transport / Logistic issues / Storage capacity issues
Dosage Form:
Injection,solution
Supply Impact Dates
From 25 May 2026
To 21 Jun 2026
Management Action:
Alternative brands are available.